Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Equipment Swab Testing for Cleaning Effectiveness – V 2.0

Posted on By

Gel Manufacturing: SOP for Equipment Swab Testing for Cleaning Effectiveness – V 2.0

Standard Operating Procedure for Equipment Swab Testing to Verify Cleaning Effectiveness


Department Gel Manufacturing
SOP No. SOP/GM/059/2025
Supersedes SOP/GM/059/2022
Page No. Page 1 of 11
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2026

1. Purpose

To establish a validated and standardized procedure for conducting equipment swab testing to verify cleaning effectiveness in gel manufacturing equipment and ensure compliance with GMP standards.

2. Scope

This SOP applies to all gel manufacturing equipment such as mixers, tanks, pipelines, and homogenizers

that undergo cleaning and require swab testing prior to reuse.

3. Responsibilities

  • QA Executive: Responsible for overseeing swab sampling and result interpretation.
  • Microbiology Analyst: Responsible for TOC and microbial limit analysis.
  • Production Chemist: Ensures readiness of equipment post-cleaning for swab collection.
See also  Gel Manufacturing: SOP for Waste Management of Gel Manufacturing Byproducts - V 2.0

4. Accountability

Head – QA and Head – Manufacturing shall ensure strict implementation of this SOP.

5. Procedure

5.1 Preparation

  1. Ensure cleaning activity has been completed and documented in the equipment logbook.
  2. Gather swab testing kit: pre-sterilized swabs, labeled sample tubes, and TOC compliant solvent.
  3. Label the sample tubes clearly with equipment ID, date, time, and sample point.

5.2 Swab Collection

  1. Use sterile gloves while handling the swab and do not touch the swabbing surface.
  2. Moisten the swab with TOC-grade water before sampling.
  3. Rub the swab over a defined surface area (typically 25 cm²) in a pattern of horizontal, vertical, and diagonal strokes.
  4. Collect swabs from the following surfaces:
    • Inner tank wall
    • Tank bottom
    • Agitator blades
    • Transfer pipeline
    • Manhole lid (internal)
  5. Place the swab into the labeled tube and seal it immediately.
See also  Gel Manufacturing: SOP for Operation of Gel Transfer Pump - V 2.0

5.3 Sample Submission

  1. Submit swab samples to the Quality Control laboratory within 2 hours of collection.
  2. Ensure chain-of-custody documentation is completed.

5.4 Analysis

  1. Perform TOC analysis for chemical residue detection.
  2. If applicable, perform microbial testing to detect bioburden post-cleaning.
  3. Compare results to acceptance limits based on cleaning validation data.

5.5 Acceptance Criteria

  • TOC < 2.0 µg/cm² for chemical residues.
  • Microbial count < 10 CFU/swab.

5.6 Documentation and Release

  1. Document all results in the swab testing register.
  2. QA to review test reports and authorize reuse of equipment.

6. Abbreviations

  • TOC: Total Organic Carbon
  • CFU: Colony Forming Units
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practices

7. Documents

  1. Swab Sampling Logbook – Annexure-1
  2. TOC and Microbial Test Report Format – Annexure-2
See also  Gel Manufacturing: SOP for Cleaning Labeling Equipment - V 2.0

8. References

  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • Schedule M: Cleaning Procedures
  • Internal Cleaning Validation Protocol

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Swab Sampling Logbook

Date Equipment ID Sample Point Swab ID Collector Remarks

Annexure-2: TOC and Microbial Test Report

Sample ID TOC (µg/cm²) CFU Count Acceptance Limit Pass/Fail QA Sign
<2.0 µg/cm², <10 CFU

Revision History

Revision Date Revision No. Details Reason Approved By
01/06/2022 1.0 Initial version New SOP QA Head
02/06/2025 2.0 Added microbial testing and updated TOC limits Compliance update QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Elixir Department: SOP for Avoiding Cross-Contamination During Manufacturing – V 2.0
Next Post: Biosimilars: SOP for Temperature Mapping of Bioreactor Jackets – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version